Table 1.

Genomic islands detection and susceptibility profile in P. aeruginosa strains associated to fatality cases in children with bacteremia.

Strain	Child gender/age	Underlying conditions	20 antimicrobials tested			GEIs detected
			S	I	R
1197	Male/8 years	Acute lymphoblastic leukemia	TI, PI, TM, PT, CA, FE, IM, AZ, AM, GE, TO, PO, CI, LO, NO, LE	CB, CT, ME	CR	PAGI-1, PAPI-1, PAPI-2, pKLC102 [2]
1210	Female/1 year	Hemophagocytic syndrome	IM, ME, AM, GE, TO, PO, CI, LO, NO, LE	CB, TI, TM, CA, FE, AZ	PI, PT, CR, CT	PAPI-1, PAPI-2 [8]
1211	Male/5 years	Aplastic anemia	TI, TM, CA, CR, FE, AZ, AM, GE, TO, PO, CI, LO, NO, LE	CB, PI, CT	PT, IM, ME	PAPI-1, PAPI-2 [8]
1212	Female/14 years	Cavernous angioma	TI, PI, TM, PT, CA, CR, CT, FE, IM, ME, AZ, AM, GE, TO, PO, CI, LO, NO, LE	CB		PAPI-1, PAPI-2 [8]
1220	Male/4 years	Osteosarcoma	AM, GE, TO, PO, NO, LE	CB, TI, PI, TM, CA, FE, AZ, CI, LO	PT, CR, CT, IM, ME	PAPI-1, PAPI-2, pKLC102 [5]
1226	Male/1 year	Biliary atresia	PO, CI, LO, NO, LE	TI	CB, PI, TM, PT, CA, CR, CT, FE, IM, ME, AZ, AM, GE, TO	PAPI-2 [11]
1239	Male/6 years	Acute myeloblastic leukemia	TI, FE, AZ, AM, GE, TO, PO, NO	CB, PI, TM, PT, CA, CI, LO, LE	CR, CT, IM, ME	PAPI-1, PAPI-2 [8]
1241	Female/7 years	Epoxy encephalopathy		PO	CB, TI, PI, TM, PT, CA, CR, CT, FE, IM, ME, AZ, AM, GE, TO, CI, LO, NO, LE	PAGI-1, PAPI-1, PAPI-2 [4]

S, Susceptible; I, Intermediate resistance; R, Resistant. CB, Carbenicillin; TI, Ticarcillin; PI, Piperacillin; TM, Ticarcillin/Clavulanic acid; PT, Piperacillin/Tazobactam; CA, Ceftazidime; CR, Ceftriaxone; CT, Cefotaxime; FE, Cefepime; IM, Imipenem; ME, Meropenem; AZ, Aztreonam; AM, Amikacin; GE, Gentamicin; TO, Tobramycin; PO, Polymyxin B; CI, Ciprofloxacin; LO, Lomefloxacin; NO, Norfloxacin; LE, Levofloxacin. GEIs, Genomic Islands; [number] correspond to GEIs genotype.